Company Overview of Intarcia Therapeutics, Inc.
Key Executives for Intarcia Therapeutics, Inc.
|Kurt C. Graves||49 Relationships||Executive Chairman, Chief Executive Officer and President||49|
|James M. Ahlers||No Relationships||Chief Financial Officer and Vice President of Finance & Operations||53|
|Michael Williams||No Relationships||Chief Operating Officer||--|
|Michelle Baron M.D., FACE||No Relationships||Chief Medical Officer and Vice President of Clinical Research||--|
|Paul L. Feldman Ph.D.||No Relationships||Head of Discovery & Translational Medicine||--|
|View More Key Executives|
Intarcia Therapeutics, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Kurt C. Graves||49 Relationships||Intarcia Therapeutics, Inc.||49|
|Bryan E. Roberts Ph.D.||117 Relationships||Castlight Health, Inc.||50|
|Glen Y. Sato J.D., M.B.A.||6 Relationships||Cooley LLP||58|
|Irwin Scher M.D.||25 Relationships||Biosynexus Incorporated||67|
|Gino Santini||64 Relationships||AMAG Pharmaceuticals, Inc.||60|
Intarcia Therapeutics, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|There is no committee data available.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.